After Reaching 52-Week High, Is Becton Dickinson and Co (BDX)’s Near-Term Analysis Positive?

June 20, 2017 - By Darrin Black

Investors sentiment increased to 0.92 in Q4 2016. Its up 0.02, from 0.9 in 2016Q3. It increased, as 52 investors sold Becton Dickinson and Co shares while 352 reduced holdings. 99 funds opened positions while 273 raised stakes. 169.86 million shares or 0.23% less from 170.25 million shares in 2016Q3 were reported.
Cidel Asset Mgmt holds 0.02% or 3,035 shares in its portfolio. Crow Point Lc reported 0.01% in Becton Dickinson and Co (NYSE:BDX). Moreover, Tci Wealth Advisors Incorporated has 0.09% invested in Becton Dickinson and Co (NYSE:BDX). Burgundy Asset Management accumulated 821,202 shares. Apg Asset Management Nv holds 538,710 shares. Veritable L P holds 0.05% or 11,931 shares. Blackrock Institutional Trust Na has invested 0.15% in Becton Dickinson and Co (NYSE:BDX). Tcw Group Inc Incorporated accumulated 21,960 shares. Cwm Llc invested in 5 shares. Alliancebernstein Lp has 363,990 shares for 0.05% of their portfolio. The Georgia-based Signaturefd Ltd Limited Liability Company has invested 0.06% in Becton Dickinson and Co (NYSE:BDX). Confluence Invest Ltd Com has invested 0.3% of its portfolio in Becton Dickinson and Co (NYSE:BDX). Parametric Portfolio Lc stated it has 883,593 shares or 0.2% of all its holdings. Franklin Resource Inc reported 3.57 million shares. Homrich & Berg reported 0.05% stake.

Since February 14, 2017, it had 0 insider purchases, and 3 insider sales for $12.53 million activity. Shares for $5.66M were sold by SHERMAN JEFFREY S. Conroy Alexandre sold $1.51 million worth of Becton Dickinson and Co (NYSE:BDX) on Tuesday, February 14.

The stock of Becton Dickinson and Co (NYSE:BDX) hit a new 52-week high and has $204.30 target or 5.00 % above today’s $194.57 share price. The 9 months bullish chart indicates low risk for the $44.49 billion company. The 1-year high was reported on Jun, 20 by Barchart.com. If the $204.30 price target is reached, the company will be worth $2.22 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

About 586,989 shares traded. Becton Dickinson and Co (NYSE:BDX) has risen 12.32% since June 20, 2016 and is uptrending. It has underperformed by 4.38% the S&P500.

Investors wait Becton Dickinson and Co (NYSE:BDX) to report on August, 3. its quarterly earnings Wall Street analysts expect $2.44 earnings per share, up $0.09 or 3.83 % from last year’s $2.35 same quarter earnings. This translates into $557.93 million profit for BDX giving the stock a 19.94 P/E. This is assuming the current $2.44 EPS is accurate. Becton Dickinson and Co’s Wall Street analysts see 6.09 % EPS growth, taking into account the $2.30 EPS reproted in the previous quarter,

Becton Dickinson and Co (NYSE:BDX) Ratings Coverage

Among 12 analysts covering Becton Dickinson (NYSE:BDX), 5 have Buy rating, 1 Sell and 6 Hold. Therefore 42% are positive. Becton Dickinson has $200 highest and $146 lowest target. $170’s average target is -12.63% below currents $194.57 stock price. Becton Dickinson had 19 analyst reports since August 7, 2015 according to SRatingsIntel. Evercore downgraded Becton Dickinson and Co (NYSE:BDX) on Wednesday, January 6 to “Hold” rating. The stock of Becton Dickinson and Co (NYSE:BDX) earned “Buy” rating by Jefferies on Thursday, March 30. Citigroup downgraded Becton Dickinson and Co (NYSE:BDX) on Friday, September 23 to “Sell” rating. On Friday, August 7 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The firm has “Buy” rating by Deutsche Bank given on Thursday, February 11. RBC Capital Markets maintained Becton Dickinson and Co (NYSE:BDX) rating on Thursday, February 4. RBC Capital Markets has “Sector Perform” rating and $153 target. The firm earned “Buy” rating on Friday, August 5 by UBS. The firm has “Buy” rating by Argus Research given on Wednesday, August 19. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, January 3. On Monday, January 4 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”.

More notable recent Becton Dickinson and Co (NYSE:BDX) news were published by: Prnewswire.com which released: “BD Announces Extension of Exchange Offers and Consent Solicitations for CR …” on June 05, 2017, also Seekingalpha.com with their article: “Becton Dickinson: Dividend Jewel – In The Service Of Medicine” published on June 20, 2017, Prnewswire.com published: “BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal …” on June 05, 2017. More interesting news about Becton Dickinson and Co (NYSE:BDX) were released by: Moodys.com and their article: “Moody’s assigns Ba1 to Becton Dickinson’s senior unsecured notes related to Bard” published on May 22, 2017 as well as Nasdaq.com‘s news article titled: “Becton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for June 07, 2017” with publication date: June 06, 2017.

Becton, Dickinson and Company is a global medical technology firm engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The company has market cap of $44.49 billion. The Firm operates through two divisions: BD Medical and BD Life Sciences. It has a 32.23 P/E ratio. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.